Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support

Hypertension Clinical Trial

Official title:

Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04577131
• Other study ID #: HM20019041
• Status: Terminated
• Phase: N/A
• Start date: November 5, 2020
• Est. completion date: November 5, 2020

Study information

• Verified date: January 2021
• Source: Virginia Commonwealth University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.

Description:

High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high.

As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker.

As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1
• Est. completion date: November 5, 2020
• Est. primary completion date: November 5, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age and older

• Uncontrolled hypertension (BP > 130/80 mm Hg)

Exclusion Criteria:

• non-English speaking patients

• patients without a mobile phone or texting capability

Related Conditions & MeSH terms

• Hypertension

Intervention

Behavioral:
• Weekly check-in
Weekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week

Locations

Country	Name	City	State
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Virginia Commonwealth University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in adherence to home blood pressure monitoring	Proportion of days blood pressure is measured based on data from the blood pressuring monitor	1 month
Primary	Change in proportion of participants with a blood pressure <130/80 mm Hg.	Proportion of participants with a blood pressure <130/80 mm Hg.	1 month